VorteFri PEN C

VorteFri is a Danish brand specializing in wart treatment products, including the VorteFri PEN C, which utilizes a potent formic acid solution to effectively remove warts. The brand is owned by Viatris, a global healthcare company headquartered in the United States, formed through the merger of Mylan and Upjohn, a division of Pfizer. The manufacturing of VorteFri products is primarily based in Italy, with some production in other locations. Viatris focuses on providing access to medicines and innovative healthcare solutions worldwide.